oncology

Glucarpidase significantly improves kidney recovery in patients experiencing nephrotoxicity caused by methotrexate, ...

JANUARY 20, 2025

The bispecific antibody amivantamab-vmjw (Rybrevant, Janssen/Johnson & Johnson) plus lazertinib (Lazcluze, ...

JANUARY 17, 2025

The future is bright for oncology, given that 1,600 drugs and vaccines for a wide variety of malignancies are in ...

JANUARY 9, 2025

The next two years may well see an explosion of FDA approvals for non-small cell lung cancer, with some of the ...

NOVEMBER 20, 2024

Fully 1,600 cancer treatments and vaccines are in development, according to speakers at an AMCP Nexus 2024 ...

NOVEMBER 18, 2024

The FDA has approved the next-generation of the multitarget stool DNA test Cologuard (Exact Sciences).

OCTOBER 28, 2024

New-onset diabetes in adults older than 50 years of age could be a manifestation of pancreatic cancer, according to ...

OCTOBER 23, 2024

Evidence is emerging for the power of fecal immunochemical testing to not only reduce colorectal cancer incidence ...

SEPTEMBER 20, 2024

Many oncology clinical trials are unable to recruit enough young people to achieve clinically meaningful results, ...

JUNE 28, 2024

Remote temperature monitoring devices may enable early detection of febrile neutropenia in adults with AML who have ...

JUNE 5, 2024

People diagnosed with CRC before 50 years of age comprise a population with its own set of circumstances and needs. ...

MAY 6, 2024

Over the past few decades, the demographics, location and stage of colorectal cancer at diagnosis have shifted, ...

APRIL 24, 2024